Related Experiment Videos

Partial deficiency of dihydroxyacetone phosphate acyltransferase activity in both classical and infantile Refsum's

Insights

Dihydroxyacetone phosphate acyltransferase (DHAP-AT) activity is reduced in Refsum's disease and Zellweger's syndrome. This suggests varying degrees of peroxisomal biogenesis defects in these related genetic disorders.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Refsum's disease (RD), infantile Refsum's disease (IRD), and Zellweger's syndrome (ZS) are genetic disorders affecting peroxisomal function.
  • Peroxisomal biogenesis defects lead to a range of clinical manifestations.

Purpose of the Study:

  • To investigate the activity of dihydroxyacetone phosphate acyltransferase (DHAP-AT) in fibroblasts from patients with RD, IRD, and ZS.
  • To determine the relationship between DHAP-AT activity and the severity of peroxisomal biogenesis defects in these diseases.

Main Methods:

  • Enzyme activity assays were performed on fibroblast cultures.
  • Fibroblast and amniocyte samples were obtained from controls and patients diagnosed with RD, IRD, and ZS.

Main Results:

  • DHAP-AT activity was severely reduced in Zellweger's syndrome fibroblasts and amniocytes.
  • A partial deficiency in DHAP-AT activity was observed in fibroblast cultures from patients with classical Refsum's disease and infantile Refsum's disease.
  • These findings indicate a correlation between DHAP-AT activity levels and the degree of peroxisomal dysfunction.

Conclusions:

  • Zellweger's syndrome, classical Refsum's disease, and infantile Refsum's disease represent distinct but related conditions.
  • The varying degrees of DHAP-AT deficiency highlight differential impacts on peroxisomal biogenesis in these disorders.

Related Concept Videos